期刊文献+

顶空气相色谱法测定非布司他原料药中有机溶剂残留 被引量:3

Determination of residual organic solvents in febuxostat bulks drug by headspace gas chromatography
原文传递
导出
摘要 目的建立了测定非布司他原料药中可能残留的7种有机溶剂(甲醇、乙醇、异丙醇、二氯甲烷、四氢呋喃、止庚烷、氯苯)的检测方法。方法采用顶空气相色谱法,色谱柱为DB-624毛细管柱(30.0m×0.531Tim×3.00μm),载气为高纯氮气;顶空温度为80℃,顶空时间为30min;柱温50℃,维持2min,以10℃/min升至200℃,维持2min;氢火焰离子化检测器(FID),温度为250℃。结果在考察的浓度范围内线性关系良好(r=0.9980-0.9998),7种残留溶剂均完全分离,精密度、重复性试验RSD值均小于5.0%,被测组分的平均回收率符合规定,供试品溶液稳定。结论该气相色谱法操作简便,准确,灵敏度高,可用于检测非布司他原料药中有机溶剂的残留物。 Objective To establish a method for determination of the seven residual organic solvents, such as methanol, ethanol, isopropanol, dichloromethane, tetrahydrofuran, n-heptane, and chlorobenzene in febuxostat bulks drug. Methods Gas headspace chromatography was applied to the study. The column was DB-624 silica capillary column (30:0 m x 0.53 mm x 3.00 μm). The initial temperature was kept at 50 °C for 2 min, then the temperature was raised to 200 °C at the rate of 10 °C/min and subsequently sustained for 2 min. FID detector temperature was 250 °C. The vial temperature was 80 °C, and the vial time was 30 min. Results There was a good linearity in the experimental concentration (r =0.998 0 - 0.999 8). The RSD values were all less than 5.0%. The average recovery was good. The test solution was stable. Conclusion The analytical method is simple, accurate and sensitive, which could be used for the quality control of residual organic solvents in febuxostat bulks drug.
作者 王琤 琚辉
出处 《现代药物与临床》 CAS 2014年第1期48-51,共4页 Drugs & Clinic
关键词 非布司他 有机溶剂残留 顶空气相色谱 febuxostat residual organic solvents headspace gas chromatography
  • 相关文献

参考文献8

二级参考文献57

  • 1常增荣,张小茜.中药提取物中的大孔吸附树脂残留物限量检查研究[J].中国中药杂志,2004,29(6):585-586. 被引量:18
  • 2胡昌勤,刘颖.《中国药典》2005年版(二部)残留溶剂检查法介绍[J].中国药品标准,2005,6(3):52-55. 被引量:13
  • 3Claudia W, Eric D. Residual solvents in pharmaceutical products acceptable limits, influences on physicochemical properties, analytical methods, and documented values[J]. Eur J Pharm Biopharm,1997, 43(3);215- 242. 被引量:1
  • 4OKAMOTO K, EGER B T, NISHINO T. An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enayme-inhibitor complex and mechanism of inhibition [ J]. J Biol Chem, 2003,278 ( 3 ) : 1848 - 1855. 被引量:1
  • 5KOMORIYA K, OSADA Y, HASEGAWA M, et al. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees [ J ]. European Journal of Pharmacology, 1993,250: 455 - 460. 被引量:1
  • 6BECKER M A,SCHUMACHER H R,WORTMANN R L, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase [ J ]. Arthritis & Rheumatism,2005,52(3) :916-923. 被引量:1
  • 7BECKER M A, SCHUMACHER H R, WORTMANN R L. Febuxostat compared with allopurinol in patients with hypemricemia and gout[ J]. N Engl J Med,2005, 353 (23) :2450 - 2461. 被引量:1
  • 8CHOI HK, MOUNT DB, REGINATO AM. Pathogenesis of gout [J]. Ann Intern Med, 2005, 143(7): 499-516. 被引量:1
  • 9OKAMOTO K, EGER BT, NISHINO T, et al. An extremely potent inhibitor of xanthine oxidoreduetase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition[J]. J Biol Chem, 2003, 278(3) : 1848-1855. 被引量:1
  • 10SCHLESINGER N. Management of acute and chronic gouty arthritis: present state-of-the-art[J]. Drugs, 2004, 64 (21) : 2399- 2416. 被引量:1

共引文献66

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部